Melissa A. Caplen

Biosimilars recently have made significant strides toward greater acceptance and utilization since their first U.S. approval in 2015, although challenges persist.

Using systemic oral corticosteroid (OCS) in treatment of chronic obstructive pulmonary disease (COPD) has risks, highlighting the need for prevention and therapy.

Thromboprophylaxis patterns of care following surgery show underutilization with respect to guideline recommendations

Milliman performed a detailed descriptive analysis to identify the characteristics and treatment patterns of potentially chimeric antigen receptor T-cell therapy eligible adult relapsed/refractory disease B-cell lymphoma patients covered by commercial insurance or Medicare fee-for-service.

This report is an analysis of how hospices’ Medicare margins relate to the characteristics of the Medicare patients served and the characteristics of the hospice itself, focusing on hospice ownership status.

This paper examines the Part D spending of Medicare patients with heart failure.

This article examines the pattern and cost of indeterminate pulmonary nodule workup in real-world practice using insurer administrative claims for commercially insured individuals.